Armstrong Advisory Group’s GSK GSK Stock Holding History

Armstrong Advisory Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-530	Closed	-$26K	–	980
2025 Q4	$26K	Hold	530	–	–	﹤0.01%	515
2025 Q3	$22.9K	Hold	530	–	–	﹤0.01%	536
2025 Q2	$20.4K	Sell	530 -1,059	-67%	-$40.5K	﹤0.01%	536
2025 Q1	$53.7K	Hold	1,589	–	–	﹤0.01%	366
2024 Q4	$53.7K	Buy	1,589 +11	+0.7%	+$396	﹤0.01%	366
2024 Q3	$64.5K	Sell	1,578 -48	-3%	-$1.96K	0.01%	334
2024 Q2	$62.6K	Buy	1,626 +7	+0.4%	+$294	0.01%	323
2024 Q1	$60K	Hold	1,619	–	–	0.01%	315
2023 Q4	$60K	Buy	1,619 +1,059	+189%	+$38K	0.01%	315
2023 Q3	$20.3K	Hold	560	–	–	﹤0.01%	483
2023 Q2	$20K	Hold	560	–	–	﹤0.01%	497
2023 Q1	$19.9K	Hold	560	–	–	﹤0.01%	479
2022 Q4	$19.7K	Buy	+560	New	+$18.7K	﹤0.01%	492

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Armstrong Advisory Group's GSK Position: Q1 2026 in Review

Armstrong Advisory Group sold out of GSK (GSK) in Q1 2026, closing a stake of 530 shares — an estimated $26K sold.

Armstrong Advisory Group first reported a position in GSK in Q4 2022 and held it in 13 quarters. The position peaked at $64.5K in Q3 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Armstrong Advisory Group reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Armstrong Advisory Group sold 530 GSK shares in Q1 2026, an estimated $26K.
Armstrong Advisory Group first reported a position in GSK in Q4 2022 and held it in 13 quarters.
Armstrong Advisory Group's GSK position peaked at $64.5K in Q3 2024.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Armstrong Advisory Group's 13F filing for Q1 2026, filed 10 Apr 2026.